% | $
Quotes you view appear here for quick access.

Supernus Pharmaceuticals, Inc. (SUPN) Message Board

  • blueboxvalue blueboxvalue Dec 13, 2012 2:54 PM Flag

    Decrease makes no sense

    Prior to the dilution announcement, the Company was trading at around $12 a share with 24.5 million shares outstanding - a market cap of $294 million. If you add the 6.9 million shares just sold and divide the $294 million cap by 31.4 million shares, the price should be $9.36. Understanding that the investors bought at a discount as an incentive to invest in the Company, they were able to purchase these shares at $8. There is no company news that I am aware of, nor any change in the business prospects of the Company or the industry as a whole to warrant the stock price to decrease to $7.20. This slide is extremely overdone in my opinion.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
20.45-0.74(-3.49%)Jul 29 4:00 PMEDT